A Web-based Study of Quality of Life Benefits Associated Aranesp in Anemic Patients With Cancer
Status:
Active, not recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
This is a web-based pilot study to evaluate the association between the treatment of anemia
with darbepoetin alfa (aranesp) and the clinical benefits in symptom palliation, improved
functional status and quality of life in patients with cancer. The feasibility of web-based
assessments and data capture will be evaluated.